• Home
  • Archives
  • Contact
Sun, July 3, 2022

Venable Fitzpatrick's Legal Updates / Medical Devices

Legal Updates/
Medical Devices

SORT BY:
OR
Home Type IPRs Filed

Recent Posts

IPRs Filed, USPTO/PTAB

Synaptive Medical Inc. requests an Inter Partes Review of Karl Storz Endoscopy-America, Inc.’s endoscopic camera patent

January 12, 2018 ­– Synaptive Medical Inc. filed a petition for inter partes review of Claims 1-19 of Patent No….

January 12, 2018
IPRs Filed, USPTO/PTAB

10X Genomics Files Three Inter Partes Review Petitions Against Bio-Rad Laboratories

January 10, 2018 – 10X Genomics, Inc. filed three inter partes review petitions to invalidate one of Bio-Rad Laboratories, Inc.’s…

January 10, 2018
IPRs Filed, USPTO/PTAB Decisions

Petition for Inter Partes Review by Orthopediatrics Corp.

On January 8, 2018, Iridex Corporation (“Plaintiff”) filed a complaint against Quantel Medical, S.A., Quantel USA, Inc., and Quantel, S.A….

January 8, 2018
IPRs Filed, USPTO/PTAB

Siemens Healthcare Diagnostics Files An Inter Partes Review Petition Against Radiometer Medical APS

December 21, 2017 – Siemens AG, Siemens Healthcare Diagnostics, Inc., Siemens Healthcare GMBH, and Siemens Medical Solutions USA, Inc., collectively,…

December 21, 2017
IPRs Filed, USPTO/PTAB

Mylan Technologies Files Two Inter Partes Review Petitions Against Noven Pharmaceuticals

December 5, 2017 – Mylan Technologies, Inc. filed two inter partes review petitions to invalidate two of Noven Pharmaceuticals, Inc.’s…

December 5, 2017
IPRs Filed, USPTO/PTAB Decisions

Nevro Corp. Petitions for Inter Partes Review of Boston Scientific’s Spinal Cord Stimulation System Technology

August 14, 2017 –– Nevro Corp. requested inter partes review of Boston Scientific Neuromodulation Corp.’s U.S. Patent No. 6,895,280, entitled…

August 14, 2017
IPRs Filed, USPTO/PTAB Decisions

Nevro Files IPR Against Boston Scientific Neuromodulation Related to Spinal Cord Stimulation System Patent

On July 24, 2017, Nevro Corp. filed a petition for inter partes review against Patent Owner Boston Scientific Neuromodulation Corp….

July 24, 2017
IPRs Filed, USPTO/PTAB

Petition for Inter Partes Review of Blood Pump Patent

April 17, 2017 – Abiomed R&D, Inc. and Abiomed, Inc. petitioned for inter partes review of claims 1-8, 10-23, 25-27,…

April 17, 2017
IPRs Filed, USPTO/PTAB

Petition for Inter Partes Review of Blood Pump Patent

April 17, 2017 – Abiomed R&D, Inc. and Abiomed, Inc. petitioned for inter partes review of claims 1-8, 10-24, and…

April 17, 2017
IPRs Filed, USPTO/PTAB

Abiomed Seeks Inter Parte Review and Declaratory Judgment of Non-Infringement of Maquet Cardiovascular’s Blood Pump Patents

On March 11, 2017, Abiomed, Inc., Abiomed R&D, Inc., and Abiomed Europe GmbH (collectively, “Abiomed”) petitioned Patent Trial and Appeal…

March 11, 2017
Load More

Popular Posts

  • IPR / PGR / CBM Medical Device Updates in February 2021
  • IPR / PGR / CBM Medical Device Updates in January 2021
  • IPR / PGR / CBM Medical Device Updates in December 2020
  • IPR / PGR / CBM Medical Device Updates in November 2020
  • IPR / PGR / CBM Medical Device Updates in October 2020

Connect With Us

ATTORNEY ADVERTISING

® /TM / © Venable LLP 2022. All Rights Reserved.

The individuals who maintain this site work for Venable LLP. The information, comments and links posted on this site do not constitute legal advice. No attorney-client relationship has been or will be formed by any communication(s) to, from or with the site and/or the author. For legal advice, contact an attorney at Venable LLP or an attorney actively practicing in your jurisdiction. Do not send any confidential or privileged information to the author; neither Venable LLP nor the author will assume any liability or responsibility for it. If you send any information, documents or materials to the site, you give permission for the author to include them on or in the site. No information, documents or materials you send to the site will be considered confidential or privileged by Venable LLP or its lawyers. Also, no such information, documents or materials will be returned to you. All decisions relating to the content belong to the author.